Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Placebo Controlled Proof of Concept Study to Investigate ANB020 Activity in Adult Patients With Severe Eosinophilic Asthma

Trial Profile

Placebo Controlled Proof of Concept Study to Investigate ANB020 Activity in Adult Patients With Severe Eosinophilic Asthma

Recruiting
Phase of Trial: Phase II

Latest Information Update: 24 Sep 2018

At a glance

  • Drugs Etokimab (Primary)
  • Indications Asthma
  • Focus Adverse reactions; Proof of concept; Therapeutic Use
  • Sponsors AnaptysBio
  • Most Recent Events

    • 24 Sep 2018 According to an AnaptysBio media release, the company plans to report full data from this trial at a medical conference in 2019 following trial completion.
    • 24 Sep 2018 Topline interim analysis results, presented in a AnaptysBio media release.
    • 26 Mar 2018 According to an AnaptysBio media release, top-line data are anticipated in the third quarter of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top